Livent Co. (NYSE:LTHM) Stock Position Trimmed by Vontobel Holding Ltd.

Vontobel Holding Ltd. cut its position in Livent Co. (NYSE:LTHMGet Rating) by 7.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 131,723 shares of the company’s stock after selling 10,467 shares during the quarter. Vontobel Holding Ltd. owned about 0.08% of Livent worth $3,434,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. U.S. Capital Wealth Advisors LLC increased its stake in Livent by 6.8% during the 1st quarter. U.S. Capital Wealth Advisors LLC now owns 196,762 shares of the company’s stock valued at $5,130,000 after buying an additional 12,530 shares during the period. Great West Life Assurance Co. Can increased its stake in Livent by 0.4% during the 1st quarter. Great West Life Assurance Co. Can now owns 139,532 shares of the company’s stock valued at $3,734,000 after buying an additional 529 shares during the period. BlackRock Inc. grew its stake in shares of Livent by 3.2% in the 1st quarter. BlackRock Inc. now owns 25,674,467 shares of the company’s stock worth $669,334,000 after purchasing an additional 797,187 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in shares of Livent by 9.5% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 197,693 shares of the company’s stock worth $5,154,000 after purchasing an additional 17,174 shares during the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Livent by 9.3% in the 1st quarter. Rhumbline Advisers now owns 416,737 shares of the company’s stock worth $10,864,000 after purchasing an additional 35,322 shares during the last quarter. 87.57% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on LTHM shares. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Livent from $29.00 to $24.00 and set a “hold” rating on the stock in a research note on Wednesday, July 6th. CICC Research assumed coverage on shares of Livent in a report on Monday, August 8th. They issued an “outperform” rating and a $27.30 target price for the company. Mizuho decreased their target price on shares of Livent from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Thursday, August 4th. Citigroup raised their target price on shares of Livent to $27.00 in a report on Tuesday, August 9th. Finally, TheStreet upgraded shares of Livent from a “c+” rating to a “b-” rating in a report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $29.39.

Livent Price Performance

NYSE LTHM opened at $34.70 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.60 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $6.22 billion, a PE ratio of 63.09 and a beta of 1.88. The company has a 50 day moving average price of $26.48 and a two-hundred day moving average price of $25.54. Livent Co. has a 12-month low of $19.35 and a 12-month high of $35.00.

Livent (NYSE:LTHMGet Rating) last posted its earnings results on Tuesday, August 2nd. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.07. Livent had a net margin of 18.36% and a return on equity of 14.62%. During the same period in the previous year, the firm earned $0.04 earnings per share. As a group, equities analysts predict that Livent Co. will post 1.38 earnings per share for the current fiscal year.

About Livent

(Get Rating)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.

Featured Stories

Institutional Ownership by Quarter for Livent (NYSE:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.